Posterior fossa medulloblastoma in children and young adults (0-19 years): survival and performance
- PMID: 10502004
- DOI: 10.1007/s003810050437
Posterior fossa medulloblastoma in children and young adults (0-19 years): survival and performance
Abstract
The objective of this study was to present survival data and outcome status in the long-term survivors of a consecutive series of 111 children and young adults treated for posterior fossa medulloblastoma in our departments from 1960 to 1997. The total surgical mortality was 13%. The surgical mortality rate declined significantly during the time period overall, from 23% before 1970 to 0% after 1990. The 5-year survival rate for patients treated between 1960 and 1973 was 0%, while 5-year survival for patients treated after the introduction of systematic craniospinal radiation in 1974 was 53%. Thirty-four patients were alive at the close of this study, with a mean observation time of 13.5 years. Over half, 61%, of the patients had one or more major deficits/problems with respect to learning ability, power of locomotion, sociability, hobbies and relationships with the opposite sex. A younger age at the time of treatment was correlated with larger deficits/problems in these variables. The correlation between young age at the time of treatment and short final height was significant. The frequency of a second neoplasm was 14%. In all but 3 cases the major cause of permanent deficits/problems was radiation therapy.
Similar articles
-
Medulloblastomas.Neurochirurgia (Stuttg). 1993 May;36(3):87-9. doi: 10.1055/s-2008-1053802. Neurochirurgia (Stuttg). 1993. PMID: 8321384
-
Medulloblastoma in children--the Ottawa experience.Childs Nerv Syst. 2000 Jun;16(6):341-50. doi: 10.1007/s003810050529. Childs Nerv Syst. 2000. PMID: 10933229
-
Medulloblastoma: treatment results with radiation therapy.South Med J. 1981 Sep;74(9):1047-9. South Med J. 1981. PMID: 7280749
-
Cerebellar medulloblastoma in adults: report of 15 cases and review of the literature.Acta Neurol (Napoli). 1994 Feb-Apr;16(1-2):38-45. Acta Neurol (Napoli). 1994. PMID: 8073915 Review.
-
[Childhood medulloblastoma].Arch Pediatr. 2008 Dec;15(12):1794-804. doi: 10.1016/j.arcped.2008.09.021. Epub 2008 Nov 7. Arch Pediatr. 2008. PMID: 18995998 Review. French.
Cited by
-
Deficits in physical function among young childhood cancer survivors.J Clin Oncol. 2013 Aug 1;31(22):2799-805. doi: 10.1200/JCO.2012.47.8081. Epub 2013 Jun 24. J Clin Oncol. 2013. PMID: 23796992 Free PMC article.
-
Radiation Induced Cavernomas in the Treatment of Pediatric Medulloblastoma: Comparative Study Between Proton and Photon Radiation Therapy.Front Oncol. 2021 Oct 11;11:760691. doi: 10.3389/fonc.2021.760691. eCollection 2021. Front Oncol. 2021. PMID: 34707999 Free PMC article.
-
Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.J Neurooncol. 2014 Sep;119(2):343-51. doi: 10.1007/s11060-014-1484-4. Epub 2014 May 31. J Neurooncol. 2014. PMID: 24879375
-
Final height and insulin-like growth factor-1 in children with medulloblastoma treated with growth hormone.Childs Nerv Syst. 2013 Oct;29(10):1859-63. doi: 10.1007/s00381-013-2124-6. Epub 2013 Jun 18. Childs Nerv Syst. 2013. PMID: 23775040
-
Physical function patient-reported outcomes among adolescent and young adult cancer survivors: A systematic review.Cancer Med. 2024 Mar;13(6):e7046. doi: 10.1002/cam4.7046. Cancer Med. 2024. PMID: 38520164 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources